Medical and Hospital News  
EPIDEMICS
Brazil's Lula to visit Mozambican anti-retroviral plant

by Staff Writers
Maputo (AFP) Nov 7, 2010
Brazilian President Luiz Inacio Lula da Silva will visit what is set to become Africa's first public factory to produce anti-AIDS drugs, during a state visit to Mozambique that begins Tuesday.

The two-day visit will bookend his presidency, underscoring his efforts to reach out to Africa by helping Mozambique, a fellow former Portuguese colony, follow in Brazil's footsteps in the fight against AIDS.

Lula, who hands over the reins to protege Dilma Rousseff on January 1, is stopping in Mozambique en route to the G20 summit in South Korea, one of eight foreign trips planned for his final days in office, according to state news agency Agencia Brasil.

"President Lula will visit the site of the future anti-retroviral factory during his visit," Mozambican health ministry spokesman Leonardo Chavane told AFP.

"The project is the product of a collaboration between Brazil and Mozambique."

The factory, which aims to help Mozambique increase the availability and affordability of HIV medication, was conceived during Lula's state visit to Mozambique during his first year in office in 2003.

Brazil famously offers free anti-retroviral (ARV) treatment to every HIV-positive citizen, a programme that sparked controversy when it was announced in 1996 because of concerns about drug resistance and violation of pharmaceutical copyrights.

But it has since been praised as a model for the developing world, with the World Bank estimating the free medicine saved more than half a million lives.

Chavane said the new factory will make the fight against AIDS more efficient in Mozambique, where 2.5 million people -- 11.5 percent of the population -- are living with HIV but just 200,000 take ARVs, according to the UN AIDS agency.

"Currently, the anti-retrovirals used in Mozambique are purchased in Europe, India or the United States. That makes them very expensive because of the transportation costs," Chavane said.

"The factory will allow us to increase the amount of medication available while lowering the cost. That will help us fight AIDS more efficiently."

While several private laboratories in Africa have ventured into small-scale ARV production, the Mozambican factory will be the first public facility on the continent to produce the drugs.

An opening date for the plant has not been set, but Chavane said it is on track for completion in 2011 after the first machine arrived last week.

Brazil has pledged 20 million dollars (14 million euros) for the 26-million-dollar project -- eight million dollars in equipment and 12 million dollars in licensing fees.

Besides touring the factory, Lula is also scheduled to launch an agricultural development programme and speak at the national teachers' university during his visit.



Share This Article With Planet Earth
del.icio.usdel.icio.us DiggDigg RedditReddit
YahooMyWebYahooMyWeb GoogleGoogle FacebookFacebook



Related Links
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


EPIDEMICS
Tiny variants in protein are key to natural HIV resistance
Washington (AFP) Nov 4, 2010
Tiny variants in a protein that alerts the body to infection could explain how one in 300 HIV-infected people are able to resist the onset of AIDS for years without needing any treatment, researchers said Thursday. "HIV is slowly revealing its secrets... Knowing how an effective immune response against HIV is generated is an important step toward replicating that response with a vaccine," sa ... read more







EPIDEMICS
A catalogue of deadly disasters in Indonesia

UN warns of aid shortfall for Pakistan flood victims

UN raises winter funds alarm in flood-hit Pakistan

81,000 homeless need aid after Myanmar cyclone: UN

EPIDEMICS
Few Americans using location-based services: Pew study

GPS maker Garmin hanging up on smartphones

Savi Challenges You To Imagine The Best Wireless Applications

European Satellite Navigation Competition Awards

EPIDEMICS
Brain Trumps Hand In Stone Age Tool Study

Oldest Ground-Edge Implement Discovered In Northern Australia

New Statistical Model Moves Human Evolution Back Three Million Years

Stone Age Humans Needed Bigger Brains For Better Tool Design

EPIDEMICS
Japan 'Cove' town should try ecotourism: dolphin activist

Climate change threatens grizzlies

Researchers Could Use Plant Light Switch To Control Cells

Earth's First Great Predator Wasn't

EPIDEMICS
Sweet Discovery Raises Hope For Treating Deadly Fast-Acting Viruses

Brazil's Lula to visit Mozambican anti-retroviral plant

Tiny variants in protein are key to natural HIV resistance

Haiti cholera death toll spikes by 105: official

EPIDEMICS
Chinese artist Ai Weiwei blasts 'inhuman' Communist regime

Police stop China environmentalist from seeking retrial

China warns Western envoys off Nobel ceremony: diplomats

Disney's Shanghai theme park takes step forward

EPIDEMICS
China says ship, crew hijacked off Somalia in June rescued

Pirates claim nine million dollar ransom for S.Korean tanker

Latin America and money laundering

Somalia pirates take South Korean trawler

EPIDEMICS
World leaders lock horns over economic overhaul

China's Hu calls for Portuguese cooperation on reform agenda

Post-vote Obama era takes nasty turn for European economy

Hong Kong land auction raises hopes of market cool-down


The content herein, unless otherwise known to be public domain, are Copyright 1995-2010 - SpaceDaily. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by SpaceDaily on any Web page published or hosted by SpaceDaily. Privacy Statement